The approval, said to be the first Bacillus coagulans approval in the South American country, opens up the Venezuelan market, and the company has signed an exclusive distribution partnership with Biotecnologia 3000 C.A.
“Venezuela is a major player in the South American region of Latin America. Having a partnership with a distributor such as Biotecnologia3000 that has the same focus, along with a substantial understanding of the market, will be a key factor to our success,” said Mike Bush, Ganeden Biotech VP of Business Development.
“There is a lot of opportunity in Venezuela for a probiotic such as GanedenBC30,” added Kristina Antonorsi, General Manager of Biotecnologia3000. “Probiotics have been used in Venezuela, but we have never been able to do the type of applications that GanedenBC30 is able to achieve. Venezuelans are becoming increasingly health conscious and are interested in consuming functional foods and beverages.
“We are excited to introduce GanedenBC30 to the Venezuelan population, and provide them access to innovative food and beverage products that provide digestive and immune system benefits.”